New Anthrax Vaccine Possible

Published on Security Management (http://www.securitymanagement.com)

By Sherry Harowitz, Editor-in-Chief

Created 08/17/2007 - 16:53

Wrap-Up?:

Weight:

Lead Headline?:

Date:

08/17/2007

By Line:

By Sherry Harowitz, Editor-in-Chief

Teaser:

An exotic anthrax vaccine administered in just a couple of doses through the nose could provide better protection than the standard vaccine, according to a report in Newscientist.com.

An exotic anthrax vaccine administered in just a couple of doses through the nose could provide better protection than the standard vaccine, according to a report in New Scientist [1]. "It involves six injections over 18 months followed by annual boosters. The breakthrough is part of an emerging trend in vaccinations away from injections towards nasal doses," the Web site states.

The article further explains:

Researchers at the University of Michigan in Ann Arbor, US, used an antigen derived from Bacillus anthracis,the bacterium that causes anthrax. The antigen doesn't cause sickness itself, but provokes a protective immune response.

It was tested on mice and guinea pigs. The protection was better when exposure was to the skin rather than from inhalation.

Comments

Security Management is the award-winning publication of ASIS International, the preeminent international
organization for security professionals, with more than 38,000 members worldwide.

ASIS International, Inc. Worldwide Headquarters, 1625 Prince Street, Alexandria, Virginia 22314-2818 U.S.A.
703.519.6200 | fax 703.519.6299 | www.asisonline.org

© 2013 Security Management
This site is protected by copyright and trade mark laws under U.S. and International law.
No part of this work may be reproduced without the written permission of Security Management.

Source URL: http://www.securitymanagement.com/news/new-anthrax-vaccine-possible

Links:
[1] http://www.newscientist.com/article.ns?id=dn12504&feedId=online-news_rss20